The Current Ratio of Zymeworks Inc. (ZYME) is
5.88.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
5.88
|
| 2024-12-31 |
3.40
|
| 2023-12-31 |
7.41
|
| 2022-12-31 |
5.70
|
| 2021-12-31 |
4.01
|
| 2020-12-31 |
5.31
|
| 2019-12-31 |
3.77
|
| 2018-12-31 |
6.81
|
| 2017-12-31 |
6.28
|
| 2016-12-31 |
2.80
|
| Ticker |
Name |
Value |
|
EPIX
|
ESSA Pharma Inc
|
38.79
|
|
TH.TO
|
Theratechnologies Inc
|
1.19
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
4.16
|
|
GBIO
|
Generation Bio Co
|
5.50
|
|
PMVP
|
Pmv Pharmaceuticals, Inc
|
10.09
|
|
ALEC
|
Alector, Inc.
|
3.83
|
|
DMTK
|
DermTech Inc
|
4.59
|
|
FUSN
|
Fusion Pharmaceuticals Inc
|
15.01
|
|
RPTX
|
Repare Therapeutics Inc
|
6.84
|
|
STOK
|
Stoke Therapeutics, Inc.
|
5.28
|
|
VBIV
|
VBI Vaccines Inc
|
0.48
|
|
FMTX
|
Forma Therapeutics Holdings Inc
|
13.86
|
|
FPRX
|
Five Prime Therapeutics Inc
|
13.18
|
|
KROS
|
Keros Therapeutics, Inc.
|
15.45
|
|
SVA.V
|
Sernova Corp
|
19.19
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
APS.TO
|
Aptose Biosciences Inc
|
0.78
|
|
IMVT
|
Immunovant, Inc.
|
9.09
|
|
KNTE
|
Kinnate Biopharma Inc
|
13.19
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
3.17
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
13.42
|
|
KRON
|
Kronos Bio LLC
|
7.54
|
|
PAND
|
Pandion Therapeutics Inc
|
2.84
|
|
QURE
|
uniQure N.V.
|
10.43
|
|
KRYS
|
Krystal Biotech, Inc.
|
9.95
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
7.02
|
|
OCGN
|
Ocugen, Inc.
|
1.06
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
9.95
|
|
REPL
|
Replimune Group, Inc.
|
4.79
|
|
ALVR
|
Allovir Inc
|
22.63
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7.81
|
|
CMPS
|
Compass Pathways PLC
|
0.77
|
|
STTK
|
Shattuck Labs Inc
|
11.70
|
|
CYTK
|
Cytokinetics, Incorporated
|
4.53
|
|
KURA
|
Kura Oncology, Inc.
|
6.06
|
|
NKTX
|
Nkarta, Inc.
|
12.69
|